Tumor Stroma Interactions
The Tumor Stroma Interactions group studies the mechanisms leading to leukemia progression.
Activities
The Tumor Stroma Interactions research group is a dynamic and multinational team studying the mechanisms leading to leukemia progression with the goal to identify new prognostic markers and therapeutic targets.
Some of the group’s research projects include:
- Exosomes in B-cell malignancies – to identify potential biomarkers in exosomes derived from murine preclinical models and cells of patients affected by hematologic malignancies and to test their influence on cells from the microenvironment.
- Tumor immunology – to identify new cellular populations which could be used as biomarkers for the response to treatment and potential new therapeutic targets.
- New therapeutic targets in CLL – to investigate the therapeutic efficacy and mode of action of new molecules inhibiting translation machinery and prohibitins in chronic lymphocytic leukemia (CLL), both in patient cells and in a murine model.
Collaborations
Projects & clinical trials
Featured team members
Scientific publications
-
The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency – 08/10/2024
-
Protocol for isolating leukemia-derived extracellular vesicles from the spleen of preclinical models of leukemia using ultracentrifugation – 05/08/2024
-
Assessment of translation rate in leukemic cells and immune cells of the microenvironment by OPP protein synthesis assay – 02/07/2024
-
Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia – 20/06/2024
-
Eμ-TCL1 adoptive transfer mouse model of chronic lymphocytic leukemia – 18/04/2024
-
Characterization of the tumor and its microenvironment in chronic lymphocytic leukemia – 14/05/2024
-
Editorial – 08/05/2024
-
PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle – 28/02/2024
-
Minimal information for studies of extracellular vesicles (MISEV2023) – 01/02/2024
-
Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors – 22/08/2023
Related News
Job vacancies
There are no jobs matching this page at the moment. You can view all jobs via the button below.